Truxima
Biological
Teva Pharmaceuticals USA, Inc.
Total Payments
$92,119
Transactions
1,046
Doctors
716
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $76,434 | 293 | 261 |
| 2023 | $5,664 | 323 | 261 |
| 2022 | $956.31 | 51 | 44 |
| 2021 | $2,176 | 129 | 96 |
| 2020 | $6,888 | 250 | 167 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $71,323 | 1 | 77.4% |
| Food and Beverage | $18,466 | 1,044 | 20.0% |
| Consulting Fee | $2,330 | 1 | 2.5% |
Payments by Type
Research
$71,323
1 transactions
General
$20,796
1,045 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Randomized phase II trial of rituximab with either pentostatin or bendamustine for multiply relapsed or refractory hairy cell leukemia | Teva Pharmaceuticals USA, Inc. | $71,323 | 0 |
Top Doctors Receiving Payments for Truxima — Page 27
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Hematology | Cerritos, CA | $13.37 | 1 |
| , MD | Rheumatology | Waco, TX | $13.29 | 1 |
| , PA | Physician Assistant | Sarasota, FL | $13.28 | 1 |
| , ACNP | Gerontology | Saint Louis, MO | $13.27 | 1 |
| , M.D | Rheumatology | Creve Coeur, MO | $13.27 | 1 |
| , MD | Hematology & Oncology | Crestview, FL | $13.23 | 1 |
| , FNP | Rheumatology | Saint Louis, MO | $13.22 | 1 |
| , M.D | Rheumatology | Saint Louis, MO | $13.21 | 1 |
| , D.O | Rheumatology | Plainfield, IN | $13.20 | 1 |
| , MD | Rheumatology | Boca Raton, FL | $13.20 | 1 |
| , N.P | Family | Baton Rouge, LA | $13.20 | 1 |
| , MD | Hematology & Oncology | Milwaukee, WI | $13.12 | 1 |
| , MD | Rheumatology | Augusta, GA | $13.10 | 1 |
| , M.D | Rheumatology | Charlotte, NC | $13.09 | 1 |
| , P.A.-C | Medical | Mesa, AZ | $13.09 | 1 |
| , MD | Rheumatology | Charlotte, NC | $13.09 | 1 |
| Elanz Tabrizi | Rheumatology | Charlotte, NC | $13.09 | 1 |
| , FNP | Family | Charlotte, NC | $13.09 | 1 |
| , MD | Rheumatology | Charlotte, NC | $13.09 | 1 |
| , M.D | Medical Oncology | Boerne, TX | $13.03 | 1 |
| , MD | Rheumatology | St George, UT | $13.01 | 1 |
| , MD | Rheumatology | Saint George, UT | $13.01 | 1 |
| , NP-C | Family | Orem, UT | $13.00 | 1 |
| , P.A | Physician Assistant | Sun City, AZ | $12.90 | 1 |
| , D.P.M | Podiatrist | Phoenix, AZ | $12.90 | 1 |
Ad
Manufacturing Companies
- Teva Pharmaceuticals USA, Inc. $92,119
Product Information
- Type Biological
- Total Payments $92,119
- Total Doctors 716
- Transactions 1,046
About Truxima
Truxima is a biological associated with $92,119 in payments to 716 healthcare providers, recorded across 1,046 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..
Payment data is available from 2020 to 2024. In 2024, $76,434 was paid across 293 transactions to 261 doctors.
The most common payment nature for Truxima is "Unspecified" ($71,323, 77.4% of total).
Truxima is associated with 1 research study, including "Randomized phase II trial of rituximab with either pentostatin or bendamustine for multiply relapsed or refractory hairy cell leukemia" ($71,323).